A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina

NCT02087007 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasospastic Angina

Interventions

DRUG: Cilostazol
DRUG: placebo

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.